AngioDynamics Inc
NASDAQ:ANGO
AngioDynamics Inc
Accounts Receivables
AngioDynamics Inc
Accounts Receivables Peer Comparison
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AngioDynamics Inc
NASDAQ:ANGO
|
Accounts Receivables
$49.5m
|
CAGR 3-Years
14%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-2%
|
|
Boston Scientific Corp
NYSE:BSX
|
Accounts Receivables
$2.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Accounts Receivables
$3.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Accounts Receivables
$6.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accounts Receivables
$1.1B
|
CAGR 3-Years
20%
|
CAGR 5-Years
16%
|
CAGR 10-Years
17%
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
Accounts Receivables
$124.4m
|
CAGR 3-Years
85%
|
CAGR 5-Years
100%
|
CAGR 10-Years
N/A
|
See Also
What is AngioDynamics Inc's Accounts Receivables?
Accounts Receivables
49.5m
USD
Based on the financial report for Feb 29, 2024, AngioDynamics Inc's Accounts Receivables amounts to 49.5m USD.
What is AngioDynamics Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
-2%
Over the last year, the Accounts Receivables growth was -3%. The average annual Accounts Receivables growth rates for AngioDynamics Inc have been 14% over the past three years , 2% over the past five years , and -2% over the past ten years .